Free. Unsubscribe any time.
Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. filed 6 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 8 transactions and 546,312 shares. None carries the SEC's AFF10B5ONE flag; all 6 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-04, came 1 day after the one before it (2026-09-03) and reports 2 transactions against 1 in the filing before it.
- The sales it reports total 11,439 shares, 8,671 more than the 2,768 in the filing before it.
- Its 6 plan statements rank 431st of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 6 have more plan statements on file than it and 4 have fewer.
- Its 6 filings on file run from 2025-01-03 to 2026-09-04, and state 5 plan adoption dates, from 2023-12-01 to 2026-06-03.
Trades in Denali Therapeutics Inc. 8
- Krognes Steve E. — 2024-12-31 · S · 30,000 shares
- SATO VICKI L — 2025-01-02 · S · 3,080 shares
- Watts Ryan J. — 2025-07-09 · S · 495,282 shares
- Ho Carole — 2025-08-12 · S · 2,937 shares
- Ho Carole — 2025-08-13 · S · 806 shares
- Schuth Alexander O. — 2026-09-01 · S · 2,768 shares
- Thornberry Nancy — 2026-09-02 · S · 10,824 shares
- Thornberry Nancy — 2026-09-02 · S · 615 shares
Adoption dates in Denali Therapeutics Inc. 5
- 2023-12-01 — stated in 1 filing
- 2024-03-21 — stated in 1 filing
- 2024-12-11 — stated in 1 filing
- 2026-03-27 — stated in 1 filing
- 2026-06-03 — stated in 1 filing
Results prints in Denali Therapeutics Inc. 7
- 2025-02-27
- 2025-05-06
- 2025-08-11
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
Trades before a print in Denali Therapeutics Inc. 0
- 33 days before the 2025-08-11 print — 2025-07-09 · S · Watts Ryan J. · 495,282 shares
- 56 days before the 2025-02-27 print — 2025-01-02 · S · SATO VICKI L · 3,080 shares
- 58 days before the 2025-02-27 print — 2024-12-31 · S · Krognes Steve E. · 30,000 shares
- 85 days before the 2025-11-06 print — 2025-08-13 · S · Ho Carole · 806 shares
- 86 days before the 2025-11-06 print — 2025-08-12 · S · Ho Carole · 2,937 shares
Interval to Denali Therapeutics Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 33shortest, days
- 3no later print
Adoption dates Denali Therapeutics Inc. states
- 2023-12-01 in 1 filing
- 2024-03-21 in 1 filing
- 2024-12-11 in 1 filing
- 2026-03-27 in 1 filing
- 2026-06-03 in 1 filing
Filing text: “10b5-1 trading plan adopted March 21, 2024”
Reported results dates on file
- 2025-02-27
- 2025-05-06
- 2025-08-11
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.